Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion type Assertion NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_head.
- NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion description "[To determine the prevalence of serum antibodies to the ionotropic glutamate receptor 3 (GluR3) in patients with Rasmussen encephalitis (RE), a severe epileptic disorder, and to compare with serum from control subjects and patients with intractable epilepsy (IE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_provenance.
- NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion evidence source_evidence_literature NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_provenance.
- NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion SIO_000772 15249609 NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_provenance.
- NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion wasDerivedFrom befree-2016 NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_provenance.
- NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_assertion wasGeneratedBy ECO_0000203 NP451731.RAcyrXoGhHRluSBnRQcQGfnCsnOb0-QgPNdwWT-RoaHmM130_provenance.